The crystal structure of guinea pig 11beta-hydroxysteroid dehydrogenase type 1 provides a model for enzyme-lipid bilayer interactions.
The metabolic reduction of 11-keto groups in glucocorticoid steroids such as cortisone leads to the nuclear receptor ligand cortisol. This conversion is an example of pre-receptor regulation and constitutes a novel pharmacological target for the treatment of metabolic disorders such as insulin resis...
Κύριοι συγγραφείς: | Ogg, D, Elleby, B, Norström, C, Stefansson, K, Abrahmsén, L, Oppermann, U, Svensson, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2005
|
Παρόμοια τεκμήρια
-
Comparative enzymology of 11 beta -hydroxysteroid dehydrogenase type 1 from glucocorticoid resistant (Guinea pig) versus sensitive (human) species.
ανά: Shafqat, N, κ.ά.
Έκδοση: (2003) -
High-level production and optimization of monodispersity of 11beta-hydroxysteroid dehydrogenase type 1.
ανά: Elleby, B, κ.ά.
Έκδοση: (2004) -
Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.
ανά: Hult, M, κ.ά.
Έκδοση: (2004) -
Glucocorticoid activation by 11beta-hydroxysteroid dehydrogenase type 1: A novel pharmacological target in the metabolic syndrome
ανά: Oppermann, U, κ.ά.
Έκδοση: (2003) -
Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
ανά: Hult, M, κ.ά.
Έκδοση: (2006)